Status:
COMPLETED
Simultaneous Corneal Wavefront-Guided Trans-PRK and Corneal Collagen Crosslinking After ICRS Implantation for Moderate Keratoconus
Lead Sponsor:
Yonsei University
Conditions:
Moderate Keratoconus
Eligibility:
All Genders
20-45 years
Brief Summary
The investigators aim to investigate the effects of combined corneal wavefront-guided transepithelial photorefractive keratectomy (tPRK) and accelerated corneal collagen cross-linking (CXL) after intr...
Detailed Description
The investigators aim to investigate the effects of combined corneal wavefront-guided transepithelial photorefractive keratectomy (tPRK) and accelerated corneal collagen cross-linking (CXL) after intr...
Eligibility Criteria
Inclusion
- intolerant to contact lenses
- moderate keratoconus without apical scarring
- if progression had been noted over the previous 6 months
- All included patients underwent combined corneal wavefront-guided tPRK and CXL at least 1 month (average 2.7 ± 1.1 months; range 1 to 4 months) after ICRS implantation.
Exclusion
- central or para-central corneal scarring
- central pachymetry \< 400 microns
- corneal endothelial cell density of less than 2000 cells/mm2
- systemic autoimmune disease
- a history of herpetic corneal disease
- pregnancy
- lactation
- severe dry eye syndrome
Key Trial Info
Start Date :
July 7 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 2 2017
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT03355430
Start Date
July 7 2016
End Date
January 2 2017
Last Update
November 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, Yonsei University College of Medicine
Seoul, South Korea, 03722